150 Medical Plaza-Rm-4230c, Los Angeles, CA, 90095 · (310) 825-6962
Beds
74
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$70.8M
FY 2025
Net income
-$30.5M
Patient care margin -33.1%
Discharges
1,699
Occupancy 89.5%
Clinicians
0
Medicare clinicians who work here
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $70.8M | $94.2M | -33.1% | -$30.5M | 1,699 | - | 11.7% | 36.2% |
Medicare clinicians who list this hospital, by specialty
No Medicare clinicians list this hospital.
Reported payments to this teaching hospital
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
| 2024 | $63.8M | $95.0M | -48.9% | -$30.7M | 1,702 | - | 15.1% | 31.5% |
| 2023 | $66.2M | $95.4M | -44.2% | -$23.1M | 1,808 | - | 16.5% | 21.5% |
| 2022 | $65.2M | $91.4M | -40.3% | -$18.8M | 1,679 | - | 18.6% | 11.6% |
| 2021 | $61.7M | $81.7M | -32.3% | -$11.0M | 1,751 | - | 18.5% | 10.6% |
| 2020 | $64.6M | $91.9M | -42.2% | -$16.9M | 1,815 | - | 20.8% | 11.7% |
| 67 |
| $773K |
| Stemline Therapeutics Inc. | 112 | $425K |
| Kite Pharma, Inc. GILD | 4 | $397K |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $391K |
| Exelixis Inc. EXEL | 45 | $161K |
| Eisai Inc. 4523.T | 8 | $116K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Resnick Neuropsychiatric Hospital at UCLA is a government-owned psychiatric hospital in Los Angeles, CA with 74 beds, part of University of California Health.
Resnick Neuropsychiatric Hospital at UCLA in Los Angeles, CA has 74 beds (fiscal year 2025 cost report); 209 beds are certified for Medicare. It discharged 1,699 inpatients that year, with 89.5% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), Resnick Neuropsychiatric Hospital at UCLA reported net patient revenue of $70.8M and operating expenses of $94.2M, a margin on patient care of -33.1%. After other income and expenses its net income was -$30.5M (-44.0% of revenue), so it lost money that year.
Resnick Neuropsychiatric Hospital at UCLA is part of University of California Health, a health system with 3 hospitals based in Oakland, CA. It is a government-owned hospital.
Resnick Neuropsychiatric Hospital at UCLA has no overall star rating, usually because it reports too few quality measures (for example small, specialty or federal hospitals).
Yes, Resnick Neuropsychiatric Hospital at UCLA provides emergency services.
In 2025, companies reported $7.4M in payments to Resnick Neuropsychiatric Hospital at UCLA as a teaching hospital ($648K general and $6.8M for research) from 29 companies.